Hims

Hims is a consumer-first multi-specialty telehealth company founded in 2017. The firm operates a direct-to-consumer digital platform that connects patients with licensed healthcare professionals for consultations, prescription medications, and personalized treatment plans. Its service portfolio spans sexual health, dermatology, mental health, weight management, and primary care. By leveraging artificial intelligence and machine learning, Hims provides tailored treatment recommendations across its digital ecosystem.

The company maintains a robust operational footprint with 1,000-5,000 employees supporting its global reach. Hims serves patients across the United States and maintains an international presence in the United Kingdom, Germany, Ireland, France, Spain, and Canada. Meet Hims's team to learn about the leadership driving this multi-specialty healthcare expansion. The organization utilizes a sophisticated e-commerce platform to deliver prescription medications, over-the-counter products, and laboratory testing services directly to consumers.

Listed on the New York Stock Exchange under the ticker symbol HIMS, the company demonstrates significant market scale with annual revenue reaching $2.4B. Hims competes with entities such as Maven Clinic, LetsGetChecked, and MDLive within the digital health sector. Explore financial highlights to review detailed metrics regarding the company's growth trajectory and fiscal performance. The firm continues to integrate retail partnerships to enhance its accessibility and service delivery model for diverse patient populations.